These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34373772)

  • 1. Corrigendum to "Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease".
    Masarone M; Rosato V; Dallio M; Gravina AG; Aglitti A; Loguercio C; Federico A; Persico M
    Oxid Med Cell Longev; 2021; 2021():9757921. PubMed ID: 34373772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum to "The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease".
    Lewis JE; Atlas SE; Higuera OL; Fiallo A; Rasul A; Farooqi A; Kromo O; Lantigua LA; Tiozzo E; Woolger JM; Goldberg S; Mendez A; Rodriguez AE; Konefal J
    Evid Based Complement Alternat Med; 2020; 2020():9575878. PubMed ID: 32328144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: NFκB/Orai1 Facilitates Endoplasmic Reticulum Stress by Oxidative Stress in the Pathogenesis of Non-alcoholic Fatty Liver Disease.
    Zhang B; Li M; Zou Y; Guo H; Zhang B; Xia C; Zhang H; Yang W; Xu C
    Front Cell Dev Biol; 2019; 7():290. PubMed ID: 31815116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease.
    J Clin Transl Hepatol; 2024 Jan; 12(1):119-121. PubMed ID: 38250468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Caffeoylquinic Acid-Rich Extract of
    Lee YJ; Jang YN; Han YM; Kim HM; Jeong JM; Son MJ; Jin CB; Kim HJ; Seo HS
    PPAR Res; 2019; 2019():5317126. PubMed ID: 31781179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum].
    Diabetes Metab Syndr Obes; 2023; 16():2833-2834. PubMed ID: 37736329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Sex-Based Differences and Risk Factors for Comorbid Nonalcoholic Fatty Liver Disease in Patients with Bipolar Disorder: A Cross-Sectional Retrospective Study [Corrigendum].
    Diabetes Metab Syndr Obes; 2024; 17():1335-1336. PubMed ID: 38525160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Manne V; Handa P; Kowdley KV
    Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.
    Masarone M; Rosato V; Dallio M; Gravina AG; Aglitti A; Loguercio C; Federico A; Persico M
    Oxid Med Cell Longev; 2018; 2018():9547613. PubMed ID: 29991976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives".
    Gitt S; Bihl F; Schepis F; Caputo F; Berenguer M
    Biomed Res Int; 2020; 2020():4305190. PubMed ID: 33224978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
    Federico A; Dallio M; Masarone M; Gravina AG; Di Sarno R; Tuccillo C; Cossiga V; Lama S; Stiuso P; Morisco F; Persico M; Loguercio C
    Oxid Med Cell Longev; 2019; 2019():8742075. PubMed ID: 31737175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease" [Free Radic. Biol. Med. 152 (2020) 116-141].
    Chen Z; Tian R; She Z; Cai J; Li H
    Free Radic Biol Med; 2021 Jan; 162():174. PubMed ID: 32571642
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Vegetarian diet, food substitution, and nonalcoholic fatty liver.
    Ci Ji Yi Xue Za Zhi; 2018; 30(3):194. PubMed ID: 30069133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.
    Savas MC; Koruk M; Pirim I; Yilmaz O; Karakok M; Taysi S; Yilmaz A
    Hepatogastroenterology; 2003; 50(51):738-41. PubMed ID: 12828075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet.
    Oliveira CP; da Costa Gayotto LC; Tatai C; Della Bina BI; Janiszewski M; Lima ES; Abdalla DS; Lopasso FP; Laurindo FR; Laudanna AA
    J Cell Mol Med; 2002; 6(3):399-406. PubMed ID: 12417056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Daliry A
    Microcirculation; 2020 Apr; 27(3):e12603. PubMed ID: 31876010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).
    Ota T
    Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity.
    Georgoulis M; Fragopoulou E; Kontogianni MD; Margariti A; Boulamatsi O; Detopoulou P; Tiniakos D; Zafiropoulou R; Papatheodoridis G
    Nutr Res; 2015 Jan; 35(1):41-8. PubMed ID: 25530013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
    Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
    Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.